cgp 42112a has been researched along with minocycline in 1 studies
| Studies (cgp 42112a) | Trials (cgp 42112a) | Recent Studies (post-2010) (cgp 42112a) | Studies (minocycline) | Trials (minocycline) | Recent Studies (post-2010) (minocycline) |
|---|---|---|---|---|---|
| 233 | 0 | 35 | 6,579 | 502 | 2,921 |
| Protein | Taxonomy | cgp 42112a (IC50) | minocycline (IC50) |
|---|---|---|---|
| Multidrug transporter MdfA | Escherichia coli K-12 | 2.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jarrott, B; Lawrence, AJ; Roulston, CL; Widdop, RE | 1 |
1 other study(ies) available for cgp 42112a and minocycline
| Article | Year |
|---|---|
Minocycline treatment attenuates microglia activation and non-angiotensin II [125I] CGP42112 binding in brainstem following nodose ganglionectomy.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Autoradiography; Brain Stem; Ganglionectomy; Immunohistochemistry; Isoquinolines; Male; Microglia; Minocycline; Nodose Ganglion; Oligopeptides; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2 | 2005 |